Only one of five key Xanax trials deemed positive by FDA
In a new study, researchers found that four of the five original studies on the effectiveness of alprazolam (Xanax) did not show it to be better than placebo. Two of the negative studies remain unpublished, while two others were presented as positive upon publication despite the drugs’ failure to beat… Continue Reading Only one of five key Xanax trials deemed positive by FDA